Stock Tips- The stock market has been witnessing huge volatility in the last few days. Foreign investors have been continuous sellers and the weak results of companies have put pressure on the market. On Thursday, November 14, the stock market closed with a decline for the third consecutive session. The 30-share BSE Sensex closed down 110.64 points at 77,580.31 and the Nifty 50 closed down 26.35 points at 23,532.70.

Amidst this ongoing turmoil in the stock market, the quarterly results of some companies have been excellent. Based on these results, brokerage firm Nuvama has advised to buy five selected stocks. The brokerage estimates that these stocks can give investors up to 61 percent return in a year.

Brokerage house Nuvama has upgraded the rating of Eicher Motors stock from HOLD to BUY. Also, the target price has been increased from Rs 4,500 to Rs 5,500 per share for the next 12 months. The stock price closed at Rs 4,890 on November 13. Operating profit (EBITDA) remained flat on a year-on-year basis in the second quarter. Royal Enfield's domestic sales are expected to remain strong in the second half (H2FY25) due to strong festive demand, focus on key models, new products, and marketing push.

Nuwama has given a BUY rating on Sun TV Network. Also, the target price has been fixed at Rs 1,040 per share for the next 12 months. The stock price closed at 730 on November 14, 2024. In this way, the stock can give a return of about 43 percent from the current price.

Brokerage Nuwama is also bullish on SKF India shares. The brokerage has maintained the buy rating of the stock and has set the target price of SKF India shares at Rs 5,716 per share from a one-year perspective. Closed at Rs 4439 on 14 November. The brokerage says that the second quarter results of SKF India have been mixed. Revenue has increased by 11 percent on an annual basis. While the EBITDA margin declined by 84 basis points (YoY) to 10 percent.

Brokerage house Nuvama has also advised to buy Galaxy Surfactants stock. The target price of the stock has been fixed at Rs 4,067 per share from the perspective of the next 12 months. The share price closed at Rs 2739 on 14 November 2024. In the second quarter, the company's revenue jumped 8 percent on an annual basis.

Nuvama has also given a BUY rating to MedPlus Health Services stock. This stock closed at Rs 705 on 14 November. The brokerage has increased the target price of this stock from Rs 1,000 to Rs 1,100 per share for the next 12 months. Thus, the stock can give a return of about 61 percent from the current price.